Patents Assigned to NeXstar Pharmacueticals, Inc.
  • Patent number: 5527894
    Abstract: Methods are described for the production of nucleic acid ligands to the HIV-1 tat protein. Motifs I, II and III in FIG. 3 are nucleic acid ligands identified by the disclosed methods.
    Type: Grant
    Filed: May 17, 1994
    Date of Patent: June 18, 1996
    Assignee: NeXstar Pharmacueticals, Inc.
    Inventors: Larry M. Gold, Craig Tuerk